Related Experiment Video
Updated: May 27, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
B cell dysfunction in chronic hepatitis B virus infection
Lijie Ma1, Xuehua Sun1, Xiaoni Kong1
1Institute of Clinical Immunology, Department of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Insights
Chronic hepatitis B (CHB) involves impaired B cell function, hindering antibody production against hepatitis B virus (HBV). This review explores B cell dysfunction mechanisms to guide new CHB treatments.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Chronic hepatitis B (CHB) is a significant global health issue.
- Functional cure of CHB requires antibodies against hepatitis B surface antigen (HBsAg).
- Adaptive immune responses in CHB patients are often inefficient.
Purpose of the Study:
- To review B cell dysfunction in chronic hepatitis B (CHB) infection.
- To elucidate potential mechanisms underlying B cell dysfunctions.
- To provide insights for novel CHB therapeutic strategies.
Main Methods:
- Literature review of studies on B cell responses in CHB.
- Analysis of B cell subsets and their functions in CHB patients.
- Examination of mechanisms contributing to B cell impairment.
Main Results:
- B cells exhibit dysfunction in HBsAg antibody production and antigen presentation.
- CHB patients show increased atypical memory B cells (CD19+CD10-CD27-CD21-) and regulatory B cells (CD19+CD24hiCD38hi).
- Dysfunctional B cells contribute to the failure of adaptive immunity against HBV.
Conclusions:
- B cell abnormalities play a critical role in CHB pathogenesis.
- Understanding these B cell dysfunctions offers new therapeutic targets.
- Further research into B cell mechanisms can advance CHB treatment and functional cure.
Abstract:
Chronic hepatitis B (CHB) remains a global health problem. The persistence of hepatitis B surface antigen (HBsAg) in the blood for longer than 6 months after the initial infection is a sign of CHB. The therapeutic goal for the functional cure of CHB is the generation of antibodies against HBsAg. However, the adaptive immune response of patients with CHB cannot generate an efficient antiviral response. Many previous studies have evaluated T cell function and T cell therapy specifically designed to counter hepatitis B virus (HBV) infection. As one of the major components of adaptive immunity, B cells also display dysfunctions in anti-HBsAg antibody (HBsAb) production and antigen presentation. Patients with CHB have amplification of CD19+CD10-CD27-CD21- atypical memory B cell subsets and CD19+CD24hiCD38hi regulatory B cells. Currently, no reviews have summarized specific B cell responses during CHB infection. Thus, in this study, we summarized B cell dysfunction during CHB progression and the potential mechanisms behind these dysfunctions to further our understanding of the mechanisms of adaptive immune response of B cells in the process of CHB development and help provide new methods and ideas for the treatment of CHB.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
10:25"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...